logo-loader
OTCMKTS:ARTH

Arch Therapeutics

Receive alerts
Market:
OTCMKTS
Market Cap:
$46.43 m
Price
$0.27
Change
-0.93%
52 weeks high
0.62
52 weeks low
0.25

In brief

Arch Therapeutics, Inc. (Arch), formerly Almah, Inc engaged in developing polymers containing peptides intended to form gel-like barriers over wounds to stop or control bleeding and seal wouds. The Company is a medical device company offering an elegant and superior approach to the rapid cessation of bleeding (hemostasis) and control of fluid leakage (sealant) during surgery and trauma care.